The U.S. Department of Transportation published a final rule April 23 that makes technical corrections to regulations governing drug testing for safety-sensitive employees to ensure consistency with recent amendments made to DOT’s “Procedures for Transportation Workplace Drug and Alcohol Testing Programs,” which recently added requirements for testing for oxycodone, oxymorphone, hydrocodone and hydromorphone.
According to the release from DOT, the new changes to the department’s regulations make it necessary to refer to these substances, as well as morphine, 6-acetylmorphine and codeine by the term “opioids” rather than “opiates.”
This final rule amends the term in the FAA, FTA and PHMSA regulations to ensure that all DOT drug testing rules are consistent with one another and the mandatory guidelines for the testing program.
Click here to read more about this final rule.
Related News
- Senate Strikes Down Spending Bill’s Harmful AI Provision
- Razor blade found on brake wheel
- Coming Soon: SMART-TD Voluntary Income & Life Protection (VILP) Program
- Senate Passes Tax Bill Without Including Railroaders
- SMART-TD Honors the Retirement of Brother Greg Hynes: A Visionary, a Fighter, and a Legend
- SMART-TD Calls on U.S. Senate to Support the Cantwell Amendment and Protect Rail Workers
- Yardmaster Protection Act Introduced
- PHOTO GALLERY: 2025 Denver Regional Training Seminar
- Fighting for Stronger Heat Protections for Rail Workers
- Regional Training Seminar Sets (Mile-High) Record in Denver